Effects of Soft Tissue Mobilization Technique and Piriformis Muscle Stretching Among Patients Having Piriformis Syndrome

Sponsor
Neuro Counsel Hospital, Pakistan (Other)
Overall Status
Completed
CT.gov ID
NCT05680402
Collaborator
Physiotherapy Clinic Iqra University Islamabad (Chak Shahzad) (Other), Noor Hospital Tarnol, Islamabad (Other)
30
1
2
2.8
10.7

Study Details

Study Description

Brief Summary

It is a randomized control trail in which soft tissue mobilization and piriformis stretching will be compared and study duration will be of five months

Condition or Disease Intervention/Treatment Phase
  • Other: Soft Tissue mobilization
  • Other: Piriformis Syndrome (Piriformis muscle stretching)
N/A

Detailed Description

Piriformis syndrome is one of the misdiagnosed syndromes and there is no evidence available for the proper diagnosis of this syndrome. Several interventions have been adopted in the clinical setting for improvement of piriformis syndrome including therapeutic ultrasound, myofascial release, stretching, dry needling, strengthening exercises of hip muscles and activity modification. There are several treatments available for this syndrome but no comparison studies have been reported yet on soft tissue mobilization and piriformis muscle stretching. The purpose for conducting this research is to assist in establishing the effectiveness of soft tissue mobilization technique and piriformis muscle stretching in piriformis syndrome by comparison between two abovementioned treatments

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Control Clinical Trial in which group 1 will be of experimental group and group 2 will be of control groupRandomized Control Clinical Trial in which group 1 will be of experimental group and group 2 will be of control group
Masking:
Single (Participant)
Masking Description:
Single Blind RCT in which only participants will not know about the type of treatment undergoing
Primary Purpose:
Other
Official Title:
Effects of Soft Tissue Mobilization Technique and Piriformis Muscle Stretching Among Patients Having Piriformis Syndrome
Actual Study Start Date :
Oct 2, 2022
Actual Primary Completion Date :
Dec 25, 2022
Actual Study Completion Date :
Dec 26, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1

Soft tissue mobilization

Other: Soft Tissue mobilization
mobilization of soft tissues of body

Active Comparator: Group 2

Piriformis Stretching

Other: Piriformis Syndrome (Piriformis muscle stretching)
Stretching of Piriformis muscle

Outcome Measures

Primary Outcome Measures

  1. Numeric Pain Rating Scale [1 week]

    Zero means non pain and 10 Means worst type of pain

  2. Modified Oswestry Disability Index (ODI) questionnaire [1 Week]

    A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males and females with age between 25 and 45 years

  • Patients with positive piriformis test

  • Pain at least 3 according to numeric pain rating scale (NPRS)

Exclusion Criteria:
  • History of hip pain due to any diagnosed hip pathology

  • Leg length discrepancy

  • Past history of spinal surgery

  • Spinal tuberculosis

  • Rheumatoid disease,

Contacts and Locations

Locations

Site City State Country Postal Code
1 Physiotherapy Clinic Iqra University Islamabad (Chak Shahzad) Islamabad Federal Pakistan 44010

Sponsors and Collaborators

  • Neuro Counsel Hospital, Pakistan
  • Physiotherapy Clinic Iqra University Islamabad (Chak Shahzad)
  • Noor Hospital Tarnol, Islamabad

Investigators

  • Principal Investigator: Muhammad Kamran, M.Phil*, Al Nafees medical College Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Neuro Counsel Hospital, Pakistan
ClinicalTrials.gov Identifier:
NCT05680402
Other Study ID Numbers:
  • 339
First Posted:
Jan 11, 2023
Last Update Posted:
Jan 11, 2023
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2023